Explore RNA interference methods, comparing siRNA and shRNA for gene knockdown, their mechanisms, advantages, and ...
In Regents of the University of California v. Broad Institute, Inc., the Federal Circuit addressed the issue of conception and reduction to ...
Few companies stand better poised than Beam Therapeutics to reap the first fruits of the FDA’s promised flexibility toward ...
Researchers explored a novel strategy involving CRISPR–Cas3 and investigated its potential using a mouse model of ...
Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for ...
ITI-5000 utilizes nucleic acid vaccine constructs engineered to preferentially deliver tumor-associated antigens (TAAs) to the MHC II compartment via LAMP-1, potentially enhancing antigen presentation ...
SenseUP’s platform tech could overcome the cost and stability hurdles holding back RNAi-based crop protection, claims the ...
Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for myotonic dystrophy type 1 (DM1), the most common adult-onset form of ...
Researchers from the Wilmer Eye Institute, Johns Hopkins Medicine Center for Nanomedicine—which designs nanotechnology-based ...
Empa has developed polymer-based, MRI-compatible electrode cables in collaboration with Swiss company TI Solutions AG, addressing long-standing safety and performance challenges associated with using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback